Gritstone Bio Inc (GRTS)
0.8161
+0.08
(+10.49%)
USD |
NASDAQ |
Apr 24, 16:00
0.8161
0.00 (0.00%)
After-Hours: 16:56
Gritstone Bio Price to Book Value: 1.543 for April 24, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
April 23, 2024 | 1.397 |
April 22, 2024 | 1.41 |
April 19, 2024 | 1.393 |
April 18, 2024 | 1.407 |
April 17, 2024 | 1.409 |
April 16, 2024 | 1.460 |
April 15, 2024 | 1.398 |
April 12, 2024 | 1.591 |
April 11, 2024 | 1.744 |
April 10, 2024 | 1.790 |
April 09, 2024 | 1.851 |
April 08, 2024 | 1.910 |
April 05, 2024 | 1.835 |
April 04, 2024 | 1.958 |
April 03, 2024 | 2.251 |
April 02, 2024 | 2.270 |
April 01, 2024 | 4.445 |
March 28, 2024 | 4.861 |
March 27, 2024 | 5.296 |
March 26, 2024 | 4.899 |
March 25, 2024 | 5.088 |
March 22, 2024 | 5.182 |
March 21, 2024 | 5.315 |
March 20, 2024 | 5.163 |
March 19, 2024 | 5.126 |
Date | Value |
---|---|
March 18, 2024 | 4.672 |
March 15, 2024 | 4.501 |
March 14, 2024 | 4.237 |
March 13, 2024 | 4.464 |
March 12, 2024 | 4.747 |
March 11, 2024 | 4.558 |
March 08, 2024 | 5.012 |
March 07, 2024 | 4.899 |
March 06, 2024 | 4.123 |
March 05, 2024 | 3.858 |
March 04, 2024 | 4.028 |
March 01, 2024 | 3.820 |
February 29, 2024 | 5.270 |
February 28, 2024 | 5.345 |
February 27, 2024 | 5.138 |
February 26, 2024 | 4.611 |
February 23, 2024 | 4.178 |
February 22, 2024 | 3.896 |
February 21, 2024 | 3.915 |
February 20, 2024 | 3.99 |
February 16, 2024 | 4.065 |
February 15, 2024 | 4.103 |
February 14, 2024 | 4.103 |
February 13, 2024 | 3.915 |
February 12, 2024 | 4.235 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6812
Minimum
May 25 2022
7.732
Maximum
Jan 22 2021
2.173
Average
1.912
Median
Price to Book Value Benchmarks
Precision BioSciences Inc | 3.601 |
Humacyte Inc | 33.63 |
Verastem Inc | 4.103 |
BioVie Inc | 2.707 |
Syros Pharmaceuticals Inc | 8.034 |
Price to Book Value Related Metrics
PS Ratio | 70.78 |
Price | 0.8161 |
Earnings Yield | -147.0% |
Market Cap | 80.03M |